Olympus (OTCMKTS:OCPNY) Research Coverage Started at The Goldman Sachs Group

Posted by on Jan 14th, 2021 // Comments off

The Goldman Sachs Group initiated coverage on shares of Olympus (OTCMKTS:OCPNY) in a research note published on Monday morning, The Fly reports. The brokerage issued a conviction-buy rating on the stock.

Shares of OTCMKTS OCPNY opened at $20.03 on Monday. The stock has a market capitalization of $27.46 billion, a price-to-earnings ratio of 71.54 and a beta of 0.69. Olympus has a 12 month low of $11.09 and a 12 month high of $22.99. The firm’s 50 day simple moving average is $21.46 and its 200-day simple moving average is $20.17. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.75 and a quick ratio of 1.22.

About Olympus

Olympus Corporation manufactures and sells precision machineries and instruments worldwide. The company operates through five segments: Endoscopic Solutions Business, Therapeutic Solutions Business, Scientific Solutions Business, Imaging Business, and Others. The Endoscopic Solutions Business segment offers gastrointestinal and surgical endoscopes, video and other endoscopes system, and repair services.

Featured Article: What is the price-to-earnings growth (PEG) ratio?

The Fly

Receive News & Ratings for Olympus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Olympus and related companies with MarketBeat.com's FREE daily email newsletter.